ESOPMay 8, 2026, 04:02 PM
Arcutis Grants 269,000 RSUs & 70,000 Stock Options to 40 New Hires
AI Summary
Arcutis Biotherapeutics, Inc. reported the grant of an aggregate of 269,000 restricted stock units and options to purchase 70,000 shares of common stock to 40 newly hired employees. These awards were approved by the Compensation Committee and granted under the 2022 Inducement Plan on May 1, 2026. The restricted stock units vest over four years, while the stock options vest over four years with a one-year cliff and monthly installments thereafter, both subject to continuous employment.
Key Highlights
- Arcutis granted 269,000 restricted stock units (RSUs) to new employees.
- Options to purchase 70,000 shares of common stock were granted.
- Awards were issued to 40 newly hired employees as an inducement.
- RSUs vest 25% annually over four years from the vesting commencement date.
- Stock options vest 25% on the one-year anniversary, then monthly over three years.
- Stock options have a ten-year term and an exercise price of $23.35 per share.
- Awards were granted under the Arcutis Biotherapeutics, Inc. 2022 Inducement Plan.
Price Impact
More from ARQT